---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-26-092657"
form_type: "8-K"
ticker: "ESLA"
cik: "0001844417"
company_name: "Estrella Immunopharma, Inc."
filed_at: "2026-08-21T21:00:13+00:00"
generated_at: "2026-08-21T21:02:31.905574+00:00"
event_type: "regulatory"
sentiment: "negative"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Estrella Immunopharma receives Nasdaq bid price deficiency notice for ESLA

## Summary
- Nasdaq notified on Aug 17, 2026 that ESLA bid price stayed below $1.00 for 30 straight days (Jul 6–Aug 14).
- Company has until Feb 16, 2027 (180-day period) to regain compliance via 10 consecutive days at $1.00+.
- Reverse stock split, if used, must be completed by at least 10 business days before compliance deadline.
- If not cured, possible second 180-day extension or delisting appeal; no immediate impact on listing/trading.
- Management evaluating options to regain bid price compliance; no assurance of success.

## SEC filing metadata
- accession: 0001213900-26-092657
- form_type: 8-K
- ticker: ESLA
- cik: 0001844417
- company_name: Estrella Immunopharma, Inc.
- filed_at: 2026-08-21T21:00:13+00:00
- event_type: regulatory
- sentiment: negative
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 3.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1844417/000121390026092657/0001213900-26-092657-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1844417/000121390026092657/ea0303066-8k_estrella.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-26-092657
- JSON: https://secwatch.observer/filing/0001213900-26-092657.json
- Plain text: https://secwatch.observer/filing/0001213900-26-092657.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.